// App-Quantinova.ai

BS33 : The RAF ‘paradox breaker’ inhibitor, PLX8394, activates ERK1/2 in endothelial cells and promotes cardiac remodelling

Researchers

Presenter

  • Susanna Cooper

Principal Investigators

  • Josh Cull

  • Angela Clerk

  • Daniel Meijles

Medical Centers

  • University of Reading, UK

  • St Georges University of London, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Mitogen-activated protein kinase 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved